2019年

  • Ekker MS, Jacob MA, van Dongen MM, Aarnio K, Annamalai AK, Arauz A, Arnold M, Barboza MA, Bolognese M, Brouns R, Chuluun B, Chuluunbaatar E, Dagvajantsan B, Debette S, Don A, Enzinger C, Ekizoglu E, Fandler-Höfler S, Fazekas F, Fromm A, Gattringer T, Gulli G, Hoffmann M, Hora TF, Jern C, Jood K, Kamouchi M, Kim YS, Kitazono T, Kittner SJ, Kleinig TJ, Klijn CJM, Korv J, Lee TH, Leys D, Maaijwee NA, Martinez-Majander N, Marto JP, Mehndiratta MM, Mifsud V, Montanaro VV, Owolabi MO, Patel VB, Phillips MC, Piechowski-Iozwiak B, Pikula A, Ruiz-Sandoval JL, Sarnowski B, Schreuder FH, Swartz RH, Tan KS, Tanne D, Tatlisumak T, Thijs V, Tuladhar AM, Viana-Baptista M, Vibo R, Wu TY, Yesilot N, Waje-Andreassen U, Pezzini A, Putaala J, de Leeuw FE

    Global Outcome Assessment Life-long After Stroke in Young Adults Initiative-The GOAL Initiative: Study Protocol and Rationale of a Multicentre Retrospective Individual Patient Data Meta-Analysis.

    BMJ Open 9(11): e031144 pubmed

  • Kuroda J, Matsuo R, Yamaguchi Y, Sato N, Kamouchi M, Hata J, Wakisaka Y, Ago T, Kitazono T

    Poor glycemic control and posterior circulation ischemic stroke.

    Neurol Clin Pract 9(2): 129-139 pubmed

  • Iwase M, Fujii H, Idewaki Y, Nakamura U, Ohkuma T, Ide H, Komorita Y, Jodai-Kitamura T, Yoshinari M, Kitazono T

    Prospective study of cancer in Japanese patients with type 2 diabetes: the Fukuoka Diabetes Registry.

    Diabetol Int 10(4): 260-7 pubmed

  • Tanaka S, Ninomiya T, Hiyamuta H, Taniguchi M, Tokumoto M, Masutani K, Ooboshi H, Nakano T, Tsuruya K, Kitazono T

    Apparent treatment-resistant hypertension and cardiovascular risk in hemodialysis patients: ten-year outcomes of the Q-Cohort Study.

    Sci Rep 9(1): 1043-1050 pubmed

  • Peng F, Tsuji G, Zhang JZ, Chen Z, Furue M

    Potential role of PM2.5 in melanogenesis.

    Environ Int 132: 105063 pubmed

  • Furue M, Uchi H, Mitoma C, Hashimoto-Hachiya A, Tanaka Y, Ito T, Tsuji G

    Implications of tryptophan photoproduct FICZ in oxidative stress and terminal differentiation of keratinocytes.

    G Ital Dermatol Venereol 154(1): 37-41 pubmed

  • Fukushi JI, Tsushima H, Matsumoto Y, Mitoma C, Furue M, Miyahara H, Nakashima Y

    Influence of dioxin-related compounds on physical function in Yusho incident victims.

    Heliyon 5(10): e02702 pubmed

  • Furue K, Ito T, Tsuji G, Ulzii D, Vu YH, Kido-Nakahara M, Nakahara T, Furue M

    The IL-13-OVOL1-FLG axis in atopic dermatitis.

    Immunology 158(4): 281-286 pubmed

  • Furue M, Tsuji G

    Chloracne and Hyperpigmentation Caused by Exposure to Hazardous Aryl Hydrocarbon Receptor Ligands.

    Int J Environ Res Public Health 16(23): 4864 pubmed

  • Ulzii D, Kido-Nakahara M, Nakahara T, Tsuji G, Furue K, Hashimoto-Hachiya A, Furue M

    Scratching Counteracts IL-13 Signaling by Upregulating the Decoy Receptor IL-13Rα2 in Keratinocytes.

    Int J Mol Sci 20(13): 3324 pubmed

  • Miake S, Tsuji G, Takemura M, Hashimoto-Hachiya A, Vu YH, Furue M, Nakahara T

    IL-4 Augments IL-31/IL-31 Receptor Alpha Interaction Leading to Enhanced Ccl 17 and Ccl 22 Production in Dendritic Cells: Implications for Atopic Dermatitis.

    Int J Mol Sci 20(16): 4053 pubmed

  • Furue M, Hashimoto-Hachiya A, Tsuji G

    Aryl Hydrocarbon Receptor in Atopic Dermatitis and Psoriasis.

    Int J Mol Sci 20(21): 5424 pubmed

  • Furue M, Ulzii D, Vu YH, Tsuji G, Kido-Nakahara M, Nakahara T

    Pathogenesis of Atopic Dermatitis: Current Paradigm.

    Iran J Immunol 16(2): 97-107 pubmed

  • Furue K, Ito T, Tanaka Y, Yumine A, Hashimoto-Hachiya A, Takemura M, Murata M, Yamamura K, Tsuji G, Furue M

    Cyto/chemokine profile of in vitro scratched keratinocyte model: Implications of significant upregulation of CCL20, CXCL8 and IL36G in Koebner phenomenon.

    J Dermatol Sci 94(1): 244-251 pubmed

  • Hashimoto-Hachiya A, Tsuji G, Furue M

    Antioxidants cinnamaldehyde and Galactomyces fermentation filtrate downregulate senescence marker CDKN2A/p16INK4A via NRF2 activation in keratinocytes.

    J Dermatol Sci 96(1): 53-56 pubmed

  • Tanaka Y, Uchi H, Furue M

    Antioxidant cinnamaldehyde attenuates UVB-induced photoaging.

    J Dermatol Sci 96(3): 151-158 pubmed

  • Tanaka Y, Uchi H, Ito T, Furue M

    Indirubin-pregnane X receptor-JNK axis accelerates skin wound healing.

    Sci Rep 9(1): 18174 pubmed

  • Hamasaki H, Honda H, Suzuki SO, Shijo M, Ohara T, Hatabe Y, Okamoto T, Ninomiya T, Iwaki T

    Tauopathy in basal ganglia involvement is exacerbated in a subset of patients with Alzheimer's disease: the Hisayama study.

    Alzheimers Dement (Amst) 11: 415-423 pubmed

  • Yoshida D, Ohara T, Hata J, Shibata M, Hirakawa Y, Honda T, Uchida K, Takasugi S, Kitazono T, Kiyohara Y, Ninomiya T

    Dairy consumption and risk of functional disability in an elderly Japanese population: the Hisayama Study.

    Am J Clin Nutr 109(6): 1664-1671 pubmed

  • Hata J, Ohara T, Katakura Y, Shimizu K, Yamashita S, Yoshida D, Honda T, Hirakawa Y, Shibata M, Sakata S, Kitazono T, Kuhara S, Ninomiya T

    Association between serum β-alanine and risk of dementia.

    Am J Epidemiol 188(9): 1637-1645 pubmed

  • Izumaru K, Hata J, Nakano T, Nakashima Y, Nagata M, Fukuhara M, Oda Y, Kitazono T, Ninomiya T

    Reduced estimated GFR and cardiac remodeling: a population-based autopsy study.

    Am J Kidney Dis 74(3): 373-381 pubmed

  • Fujiwara K, Yasuda M, Hata J, Hirakawa Y, Hashimoto S, Ueda E, Iwase A, Araie M, Yoshitomi T, Ninomiya T, Sonoda KH

    Glucose tolerance levels and circumpapillary retinal nerve fiber layer thickness in a general Japanese population: the Hisayama Study.

    Am J Ophthalmol 205: 140-146 pubmed

  • Ohara T, Hata J, Tanaka M, Honda T, Yamakage H, Yoshida D, Inoue T, Hirakawa Y, Kusakabe T, Shibata M, Teraoka T, Kitazono T, Kanba S, Satoh-Asahara N, Ninomiya T

    Serum soluble triggering receptor expressed on myeloid cells 2 as a biomarker for incident dementia: the Hisayama Study.

    Ann Neurol 85(1): 47-58 pubmed

  • Ogata H, Hirakawa Y, Matsumoto K, Hata J, Yoshida D, Fukuyama S, Inoue H, Kitazono T, Ninomiya T, Nakanishi Y

    Trends in the prevalence of airflow limitation in a general Japanese population: two serial cross-sectional surveys from the Hisayama Study.

    BMJ Open 9(3): e023673 pubmed

  • Okazaki S, Morimoto T, Kamatani Y, Kamimura T, Kobayashi H, Harada K, Tomita T, Higashiyama A, Takahashi JC, Nakagawara J, Koga M, Toyoda K, Washida K, Saito S, Takahashi A, Hirata M, Matsuda K, Mochizuki H, Chong M, Paré G, O'Donnell M, Ago T, Hata J, Ninomiya T, Dichgans M, Debette S, Kubo M, Koizumi A, Ihara M

    Moyamoya disease susceptibility variant RNF213 p.R4810K increases the risk of ischemic stroke attributable to large-artery atherosclerosis.

    Circulation 139(2): 295-298 pubmed

  • Marklund M, Wu JHY, Imamura F, Del Gobbo LC, Fretts A, de Goede J, Shi P, Tintle N, Wennberg M, Aslibekyan S, Chen TA, de Oliveira Otto MC, Hirakawa Y, Eriksen HH, Kröger J, Laguzzi F, Lankinen M, Murphy RA, Prem K, Samieri C, Virtanen J, Wood AC, Wong K, Yang WS, Zhou X, Baylin A, Boer JMA, Brouwer IA, Campos H, Chaves PHM, Chien KL, de Faire U, Djoussé L, Eiriksdottir G, El-Abbadi N, Forouhi NG, Gaziano JM, Geleijnse JM, Gigante B, Giles G, Guallar E, Gudnason V, Harris T, Harris WS, Helmer C, Hellenius ML, Hodge A, Hu FB, Jacques PF, Jansson JH, Kalsbeek A, Khaw KT, Koh WP, Laakso M, Leander K, Lin HJ, Lind L, Luben R, Luo J, McKnight B, Mursu J, Ninomiya T, Overvad K, Psaty BM, Rimm E, Schulze MB, Siscovick D, Nielsen MS, Smith AV, Steffen BT, Steffen L, Sun Q, Sundström J, Tsai MY, Tunstall-Pedoe H, Uusitupa MIJ, van Dam RM, Veenstra J, Verschuren WMM, Wareham N, Willett W, Woodward M, Yuan JM, Micha R, Lemaitre RN, Mozaffarian D, Risérus U, Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Fatty Acids and Outcomes Research Consortium (FORCE)

    Biomarkers of dietary omega-6 fatty acids and incident cardiovascular disease and mortality.

    Circulation 139(21): 2422-2436 pubmed

  • Ninomiya T, Kanzaki N, Hirakawa Y, Yoshinari M, Higashioka M, Honda T, Shibata M, Sakata S, Yoshida D, Teramoto T, Takemoto S, Nishimoto S, Hata J, Kitazono T

    Serum ethylamine levels as an indicator of L-theanine consumption and the risk of type 2 diabetes in a general Japanese population: the Hisayama Study.

    Diabetes Care 42(7): 1234-1240 pubmed

  • Toyama T, Neuen BL, Jun M, Ohkuma T, Neal B, Jardine MJ, Heerspink HL, Wong MG, Ninomiya T, Wada T, Perkovic V

    Effect of SGLT2 inhibitors on cardiovascular, renal and safety outcomes in patients with type 2 diabetes mellitus and chronic kidney disease: a systematic review and meta-analysis.

    Diabetes Obes Metab 21(5): 1237-1250 pubmed

  • Mukai N, Hata J, Hirakawa Y, Ohara T, Yoshida D, Nakamura U, Kitazono T, Ninomiya T

    Trends in the prevalence of type 2 diabetes and prediabetes in a Japanese community, 1988-2012: the Hisayama Study.

    Diabetol Int 10(3): 198-205 pubmed

  • Nakamura M, Ojima T, Nagahata T, Kondo I, Ninomiya T, Yoshita K, Arai Y, Ohkubo T, Murakami K, Nishi N, Murakami Y, Takashima N, Okuda N, Kadota A, Miyagawa N, Kondo K, Okamura T, Ueshima H, Okayama A, Miura K, NIPPON DATA2010 Research Group

    Having few remaining teeth is associated with a low nutrient intake and low serum albumin levels in middle-aged and older Japanese individuals: findings from the NIPPON DATA2010.

    Environ Health Prev Med 24(1): 1-9 pubmed

  • Tanaka A, Hata J, Akamatsu N, Mukai N, Hirakawa Y, Yoshida D, Kishimoto H, Ohara T, Mizuno T, Tsuji S, Kitazono T, Ninomiya T

    Prevalence of adult epilepsy in a general Japanese population: the Hisayama study.

    Epilepsia Open 4(1): 182-186 pubmed

  • Kageyama S, Takeshita T, Takeuchi K, Asakawa M, Matsumi R, Furuta M, Shibata Y, Nagai K, Ikebe M, Morita M, Masuda M, Toh Y, Kiyohara Y, Ninomiya T, Yamashita Y

    Characteristics of the salivary microbiota in patients with various digestive tract cancers.

    Front Microbiol 10: 1780-1789 pubmed

  • Fujiwara K, Yasuda M, Hata J, Yoshida D, Kishimoto H, Hashimoto S, Yoshitomi T, Ninomiya T, Sonoda KH

    Long-term regular exercise and intraocular pressure: the Hisayama Study.

    Graefes Arch Clin Exp Ophthalmol 257(11): 2461-2469 pubmed

  • Tomiyama H, Ohkuma T, Ninomiya T, Mastumoto C, Kario K, Hoshide S, Kita Y, Inoguchi T, Maeda Y, Kohara K, Tabara Y, Nakamura M, Ohkubo T, Watada H, Munakata M, Ohishi M, Ito N, Nakamura M, Shoji T, Vlachopoulos C, Aboyans V, Yamashina A, Collaborative Group for J-BAVELs

    Steno-stiffness approach for cardiovascular disease risk assessment in primary prevention.

    Hypertension 73(3): 508-513 pubmed

  • Ueda E, Yasuda M, Fujiwara K, Hashimoto S, Ohno-Matsui K, Hata J, Ishibashi T, Ninomiya T, Sonoda KH

    Trends in the prevalence of myopia and myopic maculopathy in a Japanese population: the Hisayama Study.

    Invest Ophthalmol Vis Sci 60(8): 2781-2786 pubmed

  • Nagata T, Ohara T, Hata J, Sakata S, Furuta Y, Yoshida D, Honda T, Hirakawa Y, Ide T, Kanba S, Kitazono T, Tsutsui H, Ninomiya T

    NT-proBNP and risk of dementia in a general Japanese elderly population: the Hisayama Study.

    J Am Heart Assoc 8(17): e011652 pubmed

  • Asada M, Oishi E, Sakata S, Hata J, Yoshida D, Honda T, Furuta Y, Shibata M, Suzuki K, Watanabe H, Murayama N, Kitazono T, Yamaura K, Ninomiya T

    Serum lipopolysaccharide-binding protein levels and the incidence of cardiovascular disease in a general Japanese population: the Hisayama Study.

    J Am Heart Assoc 8(21): e013628 pubmed

  • Inaishi J, Hirakawa Y, Horikoshi M, Akiyama M, Higashioka M, Yoshinari M, Hata J, Mukai N, Kamatani Y, Momozawa Y, Kubo M, Ninomiya T

    Association between genetic risk and development of type 2 diabetes in a general Japanese population: the Hisayama Study.

    J Clin Endocrinol Metab 104(8): 3213-3222 pubmed

  • Honda T, Kishimoto H, Mukai N, Hata J, Yoshida D, Hirakawa Y, Shibata M, Ohara T, Kumagai S, Ninomiya T

    Objectively measured sedentary time and diabetes mellitus in a general Japanese population: the Hisayama Study.

    J Diabetes Investig 10(3): 809-816 pubmed

  • Salam A, Atkins E, Sundstrom J, Hirakawa Y, Ettehad D, Emdin C, Neal B, Woodward M, Chalmers J, Berge E, Yusuf S, Rahimi K, Rodgers A, Blood Pressure Lowering Treatment Trialists' Collaboration

    Effects of blood pressure lowering on cardiovascular events, in the context of regression to the mean: a systematic review of randomized trials.

    J Hypertens 37(1): 16-23 pubmed

  • Yonemoto K, Honda T, Kishimoto H, Yoshida D, Hata J, Mukai N, Shibata M, Hirakawa Y, Ninomiya T, Kumagai S

    Longitudinal changes of physical activity and sedentary time in the middle-aged and older Japanese population: the Hisayama Study.

    J Phys Act Health 16(2): 165-171 pubmed

  • Emerging Risk Factors Collaboration (Ninomiya T, Doi Y, Kiyohara Y)

    Cardiovascular risk factors associated with venous thromboembolism.

    JAMA Cardiol 4(2): 163-173 pubmed

  • NCD Risk Factor Collaboration (NCD-RisC)(Hata J, Ninomiya T)

    Rising rural body-mass index is the main driver of the global obesity epidemic in adults.

    Nature 569(7755): 260-264 pubmed

  • Larsson SC, Traylor M, Burgess S, Boncoraglio GB, Jern C, Michaelsson K, Markus HS, MEGASTROKE project of the International Stroke Genetics Consortium (Ninomiya T, Hata J)

    Serum magnesium and calcium levels in relation to ischemic stroke: Mendelian randomization study.

    Neurology 92(9): e944-e950 pubmed

  • Honda T, Ohara T, Shinohara M, Hata J, Toh R, Yoshida D, Shibata M, Ishida T, Hirakawa Y, Irino Y, Sakata S, Uchida K, Kitazono T, Kanba S, Hirata KI, Ninomiya T

    Serum elaidic acid concentration and risk of dementia: the Hisayama Study.

    Neurology 93(22): e2053-e2064 pubmed

  • Hashimoto S, Yasuda M, Fujiwara K, Ueda E, Hata J, Hirakawa Y, Ninomiya T, Sonoda KH

    Association between axial length and myopic maculopathy: the Hisayama Study.

    Ophthalmol Retina 3(10): 867-873 pubmed

  • Takayoshi K, Kusaba H, Aikawa T, Koreishi S, Sagara K, Nakano M, Komoda M, Kono M, Fukata M, Arita T, Esaki T, Akashi K, Baba E

    Hypoalbuminemia for the prediction of venous thromboembolism and treatment of direct oral anticoagulants in metastatic gastric cancer patients.

    Gastric Cancer 22(5): 988-998 pubmed

  • Kawagoe S, Nakano M, Uchino K, Arimizu K, Kajitani T, Shimokawa H, Kusumoto T, Ikejiri K, Baba E

    Analysis of Response Evaluation Criteria in Solid Tumors reduction ratio of primary chemotherapy in unresectable advanced or recurrent colorectal cancer.

    Mol Clin Oncol 11(3): 243-251 pubmed

© 2020- Center for Cohort Studies, Graduate School of Medical Sciences, Kyushu University.